PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 189 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2014. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $173,000 | -62.5% | 5,875 | 0.0% | 0.00% | -66.7% |
| Q4 2015 | $461,000 | +4.1% | 5,875 | 0.0% | 0.01% | +12.5% |
| Q3 2015 | $443,000 | -35.4% | 5,875 | 0.0% | 0.01% | -38.5% |
| Q2 2015 | $686,000 | -50.5% | 5,875 | 0.0% | 0.01% | -45.8% |
| Q1 2015 | $1,387,000 | -31.3% | 5,875 | -45.0% | 0.02% | -29.4% |
| Q4 2014 | $2,020,000 | -21.1% | 10,675 | -0.5% | 0.03% | -24.4% |
| Q3 2014 | $2,560,000 | +68.2% | 10,730 | -53.5% | 0.04% | +73.1% |
| Q2 2014 | $1,522,000 | -36.6% | 23,065 | 0.0% | 0.03% | -38.1% |
| Q1 2014 | $2,402,000 | +11.2% | 23,065 | +10.5% | 0.04% | +10.5% |
| Q4 2013 | $2,160,000 | +44.5% | 20,865 | -25.1% | 0.04% | +31.0% |
| Q3 2013 | $1,495,000 | – | 27,865 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |